The scientific community recently noted a significant endometrial cancer study retraction involving miR-215. Specifically, the International Journal of Molecular Medicine withdrew the article after discovering duplicate data. Furthermore, a concerned reader alerted the editor about Western blot data similarities. The data in Figure 1C closely resembled images previously published in the journal Nature Cell Biology. Additionally, the editorial office performed an independent analysis of other figures.

Consequently, this investigation revealed that cellular images in Figure 6B appeared in Science. Different authors from unrelated research institutes had originally published these images. Therefore, the journal retracted the paper because the data existed elsewhere before submission. The editorial office sought an explanation from the authors. However, the authors did not provide a response to the inquiries. Moreover, the editor apologized for any inconvenience to the readers.

Clinical Impact of the Endometrial Cancer Study Retraction

In addition, researchers often explore microRNAs as potential therapeutic targets in oncology. Nevertheless, this endometrial cancer study retraction highlights the necessity of rigorous data verification. Thus, clinicians should avoid using this specific data to guide future research directions. Maintaining research integrity is essential for developing reliable gynecological cancer treatments. Furthermore, journals continue to implement stricter image screening processes to prevent similar occurrences. Consequently, peer reviewers must remain vigilant when evaluating molecular biology data.

Why did the journal retract the miR-215 study?

The journal retracted the study because it contained Western blot and cellular images that appeared in previously published papers in Nature Cell Biology and Science. This duplication undermined the integrity of the original research findings.

Did the authors explain the data duplication?

No, the authors did not reply to the editorial office's requests for an explanation regarding the data similarities. Consequently, the editor proceeded with the retraction to maintain scientific standards.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional opinion. Readers should verify research integrity through official journal notices. Refer to the latest local and national guidelines for clinical practice.

References

1. Gao X et al. [Retracted] miR‑215 promotes epithelial to mesenchymal transition and proliferation by regulating LEFTY2 in endometrial cancert. Int J Mol Med. 2026 Aug undefined. doi: undefined. PMID: 42246182.

2. Nature Cell Biology.

3. Science.

4. International Journal of Molecular Medicine.